Erythromycin Tablets Recalled for Impurity Above Acceptable Limits
Zydus Pharmaceuticals is recalling Erythromycin Tablets, 250 mg, nationwide because certain lots contain N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit due to CGMP deviations.
- Product
- ERYTHROMYCIN — ERYTHROMYCIN (ERYTHROMYCIN)
- Category
- Drug
- Distribution
- Distributed nationwide